Work

A dose-escalation and expansion study of the safety and pharmacokinetics of XB002 in subjects with inoperable locally advanced or metastatic solid tumors (301)

Year: 2022

Type: article

Source: Gynecologic Oncology

DOI: 10.1016/s0090-8258(22)01523-2

Authors: Anthony Tolcher, Andrae Vandross, Melissa Johnson, Haeseong Park, Christian Scheffold, Jing Li, Neby Bekele, Shailaja Uttamsingh, Raffaella Faggioni, Susanna Ulahannan

Institutions: Sarah Cannon, Tennessee Oncology, Washington University in St. Louis, Exelixis (United States), OU Health Stephenson Cancer Center

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4295225749

FWCI: 0.284

Cites:

Cited by: 2

Related to: 10